Faculty profile

Dongsheng Tu

ResearcherPublic Health SciencesQueen's University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses may be missing. Find their university profile.

Dongsheng Tu

Researcher

Public Health Sciences

Queen's University

Kingston, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
59 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 8 research grants (6 NSERC, 2 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

151

Publications

4,035

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Biomarkers Clinical trials Density Ratio models Longitudinal data Patient reported outcomes Probability index Proportion data Subgroup analyses

Latest papers

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial
Journal of Clinical Oncology · 2026
Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Clinical Cancer Research · 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma
Nature Communications · 2026

All 151 publications

Latest funding

Refining Adjuvant treatment IN endometrial cancer Based On molecular features (RAINBO) No Specific Molecular Profile (NSMP)-ORANGE trial
CIHR · 2026 · Co-investigator
$1,575,898
Hypofractionated Alternative Radiation with MOdulation of Neoadjuvant/perioperative immunotherapY in Sarcoma (HARMONY)
CIHR · 2025 · Co-investigator
$1,407,600
A Randomized Phase III Multicentre Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
CIHR · 2024 · Co-investigator
$742,052

All 25 grants and awards

From the 150 most recent of 151 publications.

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial

Chan KKW, Chu RWK, Cheung MC, Courneya KS, O'Callaghan CJ, Vardy JL, Gill S, Friedenreich C, Wong RKS, Dhillon HM

Journal of Clinical Oncology20261 citations

DOI: 10.1200/jco-26-00765

Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Topham JT, Beckmann HM, Karasinska JM, Loree JM, Knox JJ, Kavan P, Jonker D, Welch S, Couture F, Lemay F

Clinical Cancer Research2026

DOI: 10.1158/1078-0432.ccr-26-0793

DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma

Renouf DJ, Topham JT, Loree JM, Schaeffer DF, Knox JJ, Kavan P, Jonker D, Welch S, Couture F, Lemay F

Nature Communications2026

DOI: 10.1038/s41467-026-70120-z

(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.

Valiente CM, Mittal A, Tu D, Amir E, Pater J, Dancey J, Gyawali B, Booth CM, Wilson BE

Journal of the National Cancer Institute2026

DOI: 10.1093/jnci/djag133 PMID: 42714223

Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.

Kim SI, Kim JW, Kwon JS, Ferguson SE, Sebastianelli A, Bessette P, Mahner S, Gauthier T, de Kroon C, van Driel W, Williamson K, Goffin F, Polterauer S, Eyjólfsdóttir B, Lee JY, Maguire PJ, Juhasz-Böss I, Lim H, Seol A, Shepherd L, Tu D, Plante M

Gynecologic oncology2026

DOI: 10.1016/j.ygyno.2026.01.001 PMID: 41520567

Correlation of pelvic magnetic resonance imaging with diagnostic loop electrosurgical excision procedure/cone biopsy and hysterectomy pathology: an exploratory analysis of the CX.5/SHAPE trial.

Plante M, Kwon JS, Mahner S, Cormier B, Fortin S, Theret P, Bats AS, de Kroon C, Van Driel W, Tidy J, Williamson K, Hillemanns P, Goffin F, Polterauer S, Eyjolfsdottir B, Maguire PJ, Kim SI, Atri M, Shepherd L, Tu D

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2026Senior author

DOI: 10.1016/j.ijgc.2026.104835 PMID: 42520498

A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval-Bounded Longitudinal Measurements and Survival Times With Cure Proportion.

Wang Z, Shen Z, Ming R, Tu D

Pharmaceutical statistics2026Senior author

DOI: 10.1002/pst.70072 PMID: 41618521

Effects of a structured exercise program on motivational outcomes in patients with colon cancer.

Courneya KS, Booth CM, Vardy JL, Friedenreich CM, Dhillon HM, Coyle V, Campbell KL, Arthuso FZ, Turner J, Kent DE, Russell C, Gordon JJ, Henson J, Chua NS, Jonker DJ, Kay S, Gill S, O'Brien P, Tu D, O'Callaghan CJ

Journal of the National Cancer Institute2026

DOI: 10.1093/jnci/djag023 PMID: 41609410

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

Courneya KS, Vardy JL, O'Callaghan CJ, Gill S, Friedenreich CM, Wong RKS, Dhillon HM, Coyle V, Chua NS, Jonker DJ

New England Journal of Medicine2025375 citations

DOI: 10.1056/nejmoa2502760

Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data

Coschi CH, Ding K, Tong J, Tu D, O’Callaghan C, Leighl NB, Vera-Badillo F, Juergens RA, Hao D, Seymour L

Immunotherapy20253 citations

DOI: 10.1080/1750743x.2025.2485012

Something wrong or missing on this profile? Suggest a correction

Dongsheng Tu

Research

Latest papers

Latest funding

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial

Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma

(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.

Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.

Correlation of pelvic magnetic resonance imaging with diagnostic loop electrosurgical excision procedure/cone biopsy and hysterectomy pathology: an exploratory analysis of the CX.5/SHAPE trial.

A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval-Bounded Longitudinal Measurements and Survival Times With Cure Proportion.

Effects of a structured exercise program on motivational outcomes in patients with colon cancer.

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data

Statistical Methods and Theory for Clinical Trials in the Era of Patient-Oriented Research and Personalized Medicine

Frequent collaborators

Lesley Seymour

Ian Gilron

John Goffin

Roumen Milev

Derek Jonker

Geoffrey Liu

Michael Brundage

Ming-Sound Tsao

Scott Duggan

Mark Norman Levine

Christopher O'Callaghan

Courtney Heather Coschi

Ralph Meyer

William Evans

Wei Xu

Janet Dancey

Paul Wheatley-Price

Yingwei Peng

Wei Tu

Glenwood Goss

Rosalyn Juergens

Stephen Welch

Yang Zhao

Harry Prapavessis

Bingshu Chen